As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
Source: [CNBC](https://www.cnbc.com/2026/09/25/novo-eli-lilly-obesity-drugs.html)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at CNBC ↗